This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.
Swetha Raparla, BPharm, MS
Advertisement
Articles by Swetha Raparla, BPharm, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
3
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
4
Defunding Co-Payment Assistance Disrupted nAMD Care
5